Bioethical Considerations in Telehealth Enabled Clinical Trials, An Interdisciplinary Discussion

Discover the transformative power of telehealth for diabetes management, from education and prevention to comprehensive care, as evidenced by the success stories from various programs. This enlightening webinar delves into the significant impact of telehealth on both preventing and managing diabetes, along with the evolving landscape of policies shaping its future.

With increasing provider shortages, patient wait times, and physician burnout, maximizing clinical capacity has become more critical than ever. Discover why leading direct-to-consumer health brands and provider organizations are turning to the power of asynchronous care to address these challenges.

This policy update dives into the geographic red flag issue specific to the Drug Enforcement Administration’s (DEA) oversight of remote prescribing of controlled substances. We clarify the issue, outline the key players involved, discuss potential DEA rulemaking as well as its potential impact on state policies, and highlight the urgent stakeholder statement urging the DEA to address this issue.